The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl

Blood

Volumn 99, Issue 8, 2002, Pages 2957-2968

  He, Yiping ^a,b   Wertheim, Jason A ^a,b   Xu, Lanwei ^a,b   Miller, Juli P ^a,b   Karnell, Fredrick G ^a,b   Choi, John K ^a,b   Ren, Ruibao ^a,b   Pear, Warren S ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; PROTEIN TYROSINE KINASE; TYROSINE;

ACUTE LYMPHOCYTIC LEUKEMIA; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; B CELL LEUKEMIA; BINDING SITE; BONE MARROW CELL; CELL GROWTH; CELL LINE; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; LEUKEMOGENESIS; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; T CELL LEUKEMIA;

EID: 0037089427     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.8.2957     Document Type: Article

References (35)

1. A minute chromosome in human chronic granulocytic leukemia
2. The BCR gene encodes a novel serine/threonine kinase activity within a single exon
3. Abl tyrosine kinase in signal transduction and cell-cycle regulation
4. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype
5. Chronic myeloid leukemia
6. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity
7. The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity
8. Cycling, stressed-out and nervous: Cellular functions of c-Abl
9. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins
10. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adapter protein
11. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphoty-rosine-dependent manner
12. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family
13. Growth factor independence and BCR/ABL transformation: Promise and pitfalls of murine model systems and assays
14. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis
15. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene
16. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
17. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow
18. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia
19. The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl
20. c-Abl kinase regulates the protein binding activity of c-Crk
21. Detection of c-abltyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products
22. Activation of the c-Abl tyrosine kinase in the stress response to DNA damaging agents
23. Signaling in leukemia: Which messenger to kill?
24. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment
25. α-helical coiled coils - A widespread motif in proteins
26. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia
27. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation
28. Reduced oncogenicity of p190 Bcr/Abl F-actinbinding domain mutants
29. The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase
30. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetar tyrosines 579/581
31. Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitor
32. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells
33. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL
34. v-abl causes hematopoietic disease distinct from that caused by bcr-abl
35. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles